newsfilter
← Latest News
Business Wire·

Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen®

NR is the first among NR, NMN, and NAD+ to receive a pharmacopeial quality benchmark, reinforcing Niagen Bioscience's leadership in NAD+ science and ingredient quality Niagen Bioscience, Inc. (NASDAQ:NAGE), the global